Mutations of the BRAF gene in human cancerHelen Davies, Richard Wooster, Kristian Gray et al.|Nature|2002Cited by 10.7k
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAFSonja J. Heidorn, Richard Marais|Cell|2010Cited by 1.5k
Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surfaceHaoran Tang, Richard Marais|Nature Communications|2017Cited by 87
A Mouse Model of Melanoma Driven by Oncogenic KRASCarla Milagre, Richard Marais|Cancer Research|2010Cited by 76
The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancersG. Saturno, Caroline J. Springer, Filipa M. Lopes et al.|Annals of Oncology|2020Cited by 21